Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | -0.18 | $89,296 | — |
| 2025 Q1 | -0.18 | $89,296 | — |
| 2024 Q4 | 0.00 | $0 | -$367,210 |
| 2024 Q3 | 0.00 | $0 | -$342,298 |
| 2023 Q4 | 0.00 | -$1 | -$465,263 |
| 2022 Q4 | -0.13 | $147,536 | -$652,636 |
| 2021 Q4 |
| -0.02 |
| $0 |
| -$120,922 |